EVOLUS, INC. Operating Lease, Payments
EVOLUS, INC. (EOLS) reported Operating Lease, Payments of $1.78 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-03.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-03
- EVOLUS, INC. operating lease, payments for the quarter ending 2025-03-31 was $281.00K, a 17.60% decline year-over-year.
- EVOLUS, INC. operating lease, payments for the quarter ending 2024-03-31 was $341.00K.
- EVOLUS, INC. operating lease, payments for the quarter ending 2019-12-31 was $207.00K.
- EVOLUS, INC. operating lease, payments for the quarter ending 2019-09-30 was $248.00K.
- EVOLUS, INC. operating lease, payments for fiscal 2025 was $1.78M, a 24.28% increase from fiscal 2024.
- EVOLUS, INC. operating lease, payments for fiscal 2024 was $1.43M, a 8.56% increase from fiscal 2023.
- EVOLUS, INC. operating lease, payments for fiscal 2023 was $1.32M, a 4.35% increase from fiscal 2022.
- EVOLUS, INC. operating lease, payments for fiscal 2022 was $1.26M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2025-12-31 | $1.78M 10-K · filed 2026-03-03 | |||
| 2025-03-31 | $281.00K 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | $1.43M 10-K · filed 2026-03-03 | |||
| 2024-03-31 | $341.00K 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $1.32M 10-K · filed 2026-03-03 | |||
| 2022-12-31 | $1.26M 10-K · filed 2025-03-04 | |||
| 2019-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $455.00K derived: sum of 2 quarters · filed 2020-02-25 | $685.00K derived: sum of 3 quarters · filed 2020-02-25 | $923.00K 10-K · filed 2020-02-25 |
| 2019-09-30 | $248.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $478.00K derived: sum of 2 quarters · filed 2019-11-04 | $716.00K 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $468.00K 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $238.00K 10-Q · filed 2019-05-01 | |||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $0.00 derived: sum of 2 quarters · filed 2019-11-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $0.00 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |